German Healthcare Provider Selects Sectra to Improve Radiology Workflow

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will install the radiology module of its enterprise imaging solution throughout German ANregiomed’s healthcare system, featuring three hospitals and one medical care center.

The enterprise-wide solution will facilitate efficient radiology workflows through tools for enhanced reporting efficiency as well as the ability to share resources across the sites. In turn, this will allow for shorter lead times for patients.

“With one shared solution across our different hospital sites, we now have the opportunity to utilize our resources more efficiently by providing remote reading for the sites without on-site radiologists. Together with high system performance and the solution’s ease-of-use, we see clear benefits for both our radiologists and their patients,” says Dr. Gerhard M. Sontheimer, Chief Executive Officer, ANregiomed gKU.

To provide the care team with a full patient overview, the solution will also be deeply integrated with surrounding IT systems used at the hospitals, such as the radiology information system (RIS) and the healthcare information system (HIS).

“Many healthcare providers in Germany see regional co-operation and resource sharing as important components in their commitment to delivering high-quality patient care. We are proud to have the opportunity to utilize our experience and technology to contribute to ANregiomed’s improvements to radiology workflows and beyond,” says Peter Osinga, Managing Director, Sectra DACH and Benelux.

ANregiomed consists of the hospitals Ansbach, Dinkelsbühl, Rothenburg and Feuchtwangen. The contract was signed in September 2022 and the solution will handle approximately 200,000 examinations per year.

The radiology module is part of Sectra’s enterprise imaging solution, which provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise. Visit Sectra’s website to read more about Sectra and why it’s top-ranked in “Best in KLAS“.

SourceSectra
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

LumiGuide, powered by Fiber Optic RealShape (FORS) technology, enables doctors to navigate through blood vessels using light, instead of X- ray. “[It’s] one of the most exciting changes that we’ve seen with imaging certainly throughout my career,” said Andres Schanzer, Vascular Surgeon, at UMass Memorial Medical Center, Worcester, MA, USA.
Carestream Health notes twenty-seven of the patents were awarded by the U.S. Patent and Trademark Office; an additional 43 patents were received in European and Asian countries.
According to an Insightec study, patients experienced significant reductions in upper limb tremor, tremor-related disability, and quality of life. The most common intraprocedural adverse events included dizziness, headache, nausea, and vomiting, which all resolved. Post-procedural adverse events included paraesthesia and gait disturbance, which were often transient or resolved within 12 months.
Chris Landon, Business Leader Image Guided Therapy Devices at Philips: “IVUS is a technology that has demonstrated an ability to both support safer procedures for patients and procedural staff alike including reductions in radiation exposure. As the global leader in IVUS solutions, we are grateful for the rigorous multidisciplinary approach to developing expert consensus on the value of IVUS and we look forward to working with all stakeholders to standardize the use of IVUS and reduce the barriers preventing utilization.”
"We are delighted to see our 3D solution CE-marked and available on the European market," says Ulrik Harrysson, CEO at SyntheticMR AB. "SyMRI 3D represents the next generation of quantitative MRI, offering unprecedented resolution and accuracy in brain imaging, revolutionizing the landscape of medical diagnostics."

By using this website you agree to accept Medical Device News Magazine Privacy Policy